SOMERSET, N.J. - Catalent, Inc. (NYSE ... has reached a definitive agreement to divest its Somerset, New Jersey oral solids development and small-scale manufacturing facility.

Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha ...

Catalent, Inc. , the leader in enabling the development and supply of better treatments for patients worldwide, today issued the following open letter to customers: To Catalent's Valued Customers, I ...

SOMERSET, N.J. - Catalent, Inc. (NYSE: NYSE:CTLT), a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, has reached a ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today a ...

Johnson & Johnson, a global health care and medtech company based in New Jersey, plans to invest more than $2 billion ... Fresenius Kabi, Grifols, Catalent, Merck, Novo Nordisk, Pfizer and Thermo ...

It is home to established life sciences companies such as CMP Pharma, Fresenius Kabi, Grifols, Catalent, Merck ... a global health care and medtech company based in New Jersey, plans to invest more ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

Catalent president and CEO Alessandro Maselli said on Monday he will stay on as the contract drugmaker's chief after it is ...